NCT02658968 2024-01-16
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
Nordic Nanovector
Phase 1 Completed
Nordic Nanovector
National Institute of Allergy and Infectious Diseases (NIAID)
NIH AIDS Clinical Trials Information Service